Ligand validation:8TBG

ZNI: (1R,5S,6r)-N-[(1P,7S,9S,13S,20M)-20-{5-(4-cyclopropylpiperazin-1-yl)-2-[(1S)-1-methoxyethyl]pyridin-3-yl}-21-ethyl-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetraazapentacyclo[17.5.2.1~2,5~.1~9,13~.0~22,26~]octacosa-1(24),2,5(28),19,22,25-hexaen-7-yl]-3-oxabicyclo[3.1.0]hexane-6-carboxamide

ZNI is a Ligand Of Interest in 8TBG designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8TBG_ZNI_C_202	89%	56%	0.088	0.966	0.82	0.89	1	3	0	1	100%	1
8TBG_ZNI_D_201	88%	51%	0.088	0.964	0.92	0.98	1	5	0	1	100%	1
8TBN_ZNI_D_201	97%	55%	0.061	0.979	0.73	1.02	-	2	0	1	100%	1
8TBM_ZNI_C_201	97%	57%	0.058	0.972	0.75	0.9	2	3	0	1	100%	1
8TBK_ZNI_D_201	96%	53%	0.059	0.967	0.86	0.96	2	5	0	1	100%	1
9BHO_ZNI_B_201	96%	11%	0.057	0.963	2.02	2.12	10	20	0	1	100%	1
9BGH_ZNI_B_201	94%	14%	0.065	0.965	2.03	1.87	14	15	0	1	100%	1
9BI1_ZNI_B_201	94%	11%	0.065	0.962	1.81	2.31	13	22	0	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.